DE602006013192D1 - Diagnostischer test für entzündliche endothelfehlfunktionen bei schwangerschaften - Google Patents

Diagnostischer test für entzündliche endothelfehlfunktionen bei schwangerschaften

Info

Publication number
DE602006013192D1
DE602006013192D1 DE602006013192T DE602006013192T DE602006013192D1 DE 602006013192 D1 DE602006013192 D1 DE 602006013192D1 DE 602006013192 T DE602006013192 T DE 602006013192T DE 602006013192 T DE602006013192 T DE 602006013192T DE 602006013192 D1 DE602006013192 D1 DE 602006013192D1
Authority
DE
Germany
Prior art keywords
inflammatory
diagnostic test
endothle
pregnancy
ptx3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006013192T
Other languages
English (en)
Inventor
Alberto Mantovani
Cecilia Garlanda
Andrea Doni
Irene Cetin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Humanitas Mirasole SpA
Original Assignee
Humanitas Mirasole SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Humanitas Mirasole SpA filed Critical Humanitas Mirasole SpA
Publication of DE602006013192D1 publication Critical patent/DE602006013192D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4715—Cytokine-induced proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7095—Inflammation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
DE602006013192T 2005-12-29 2006-12-18 Diagnostischer test für entzündliche endothelfehlfunktionen bei schwangerschaften Active DE602006013192D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05028630 2005-12-29
PCT/EP2006/012168 WO2007073899A1 (en) 2005-12-29 2006-12-18 Diagnostic test for inflammatory endothelial dysfunctions in pregnancies

Publications (1)

Publication Number Publication Date
DE602006013192D1 true DE602006013192D1 (de) 2010-05-06

Family

ID=37866310

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006013192T Active DE602006013192D1 (de) 2005-12-29 2006-12-18 Diagnostischer test für entzündliche endothelfehlfunktionen bei schwangerschaften

Country Status (10)

Country Link
US (1) US9081018B2 (de)
EP (1) EP1966612B1 (de)
JP (1) JP5199120B2 (de)
KR (1) KR101365906B1 (de)
CN (1) CN101351711A (de)
AT (1) ATE462141T1 (de)
AU (1) AU2006331093B2 (de)
CA (1) CA2632952A1 (de)
DE (1) DE602006013192D1 (de)
WO (1) WO2007073899A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006352299A1 (en) * 2006-12-22 2008-07-03 Humanitas Mirasole S.P.A. A method for measuring plasma levels of long pentraxin PTX3
KR101305515B1 (ko) * 2011-06-10 2013-09-06 경북대학교 산학협력단 펜트락신 3 단백질의 파킨슨 질환 진단 용도
CN102426243B (zh) * 2011-11-17 2014-03-19 成都创宜生物科技有限公司 以补体因子d为检测指标的子痫前期检测试剂盒的制备方法
GB202012830D0 (en) * 2020-08-17 2020-09-30 Univ Tartu Method of prognosing preeclampsia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04000909A (es) * 2001-08-03 2004-03-26 Sigma Tau Ind Farmaceuti Uso de pentraxina larga ptx3 para tratar la infertilidad femenina.
US20040137544A1 (en) * 2002-10-31 2004-07-15 Roberto Latini PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
US20050136542A1 (en) * 2003-12-19 2005-06-23 Beckman Coulter, Inc. Stabilized liquid reference solutions
EP1720014A4 (de) * 2004-02-25 2008-01-16 Perseus Proteomics Inc Verfahren zur beurteilung des ausmasses einer vaskulopathie
GB0408449D0 (en) * 2004-04-15 2004-05-19 Banerjee Subhasis Diagnostic and therapeutic applications of soluble lhcge protein
DE102004020144C5 (de) 2004-04-24 2011-02-03 Sartorius Ag Anordnung mehrerer seitlich nebeneinander angeordneter Wägesysteme
ITMI20040858A1 (it) * 2004-04-29 2004-07-29 Farma Dev S R L Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione

Also Published As

Publication number Publication date
CA2632952A1 (en) 2007-07-05
EP1966612A1 (de) 2008-09-10
EP1966612B1 (de) 2010-03-24
CN101351711A (zh) 2009-01-21
JP5199120B2 (ja) 2013-05-15
KR20080083038A (ko) 2008-09-12
AU2006331093A1 (en) 2007-07-05
WO2007073899A8 (en) 2007-09-13
KR101365906B1 (ko) 2014-02-21
US9081018B2 (en) 2015-07-14
JP2009525463A (ja) 2009-07-09
US20080311603A1 (en) 2008-12-18
ATE462141T1 (de) 2010-04-15
AU2006331093B2 (en) 2011-11-24
WO2007073899A1 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
EP2612928A3 (de) Marker zur pränatalen Diagnose und Überwachung
ATE508364T1 (de) Diagnoseverfahren für präeklampsie
WO2010025393A3 (en) Protein biomarkers and methods for diagnosing kawasaki disease
JP2009501333A5 (de)
NO20075906L (no) Sepsisdiagnoser
AR049279A1 (es) Adam12 como marcador de una funcion celular anormal
EP3182126A3 (de) Biomarkertest zur vorhersage oder früherkennung von präeklampsie und/oder hellp-syndrom
Javanmardi et al. Diagnostic value of cystatin C for diagnosis of early renal damages in type 2 diabetic mellitus patients: The first experience in Iran
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
WO2007051069A3 (en) Urinary proteomic biomarker patterns in preeclampsia
JP2009524014A (ja) 子癇前症の検出及び予測
NZ624609A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
DE602006013192D1 (de) Diagnostischer test für entzündliche endothelfehlfunktionen bei schwangerschaften
WO2007133586A3 (en) Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets
TR201900481T4 (tr) Bağışıklık testi için aparat ve kit.
WO2005085292A3 (fr) Procede de detection de la forme libre activable du psa et son utilisation pour le diagnostic des pathologies benignes de la prostate et de l'adenocarcinome de la prostate
WO2005103719A3 (en) Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
IT201800007264A1 (it) Metodo per la diagnosi in vitro di carcinoma della prostata mediante biomarcatori urinari
EA201290056A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
WO2008132753A3 (en) Methods and kits for detecting fetal cells in the maternal blood
MD3171174T2 (ro) Lactoferină pentru utilizarea în diagnosticul sau prognosticul bolii Alzheimer
WO2019055661A8 (en) Preeclampsia biomarkers and related systems and methods
WO2009014987A3 (en) Identification and quantification of biomarkers for evaluating the risk of preterm birth
WO2007126901A3 (en) Apparatus and method for predicting disease

Legal Events

Date Code Title Description
8364 No opposition during term of opposition